involved repairing dna researchers investigating group benefit immunotherapy larger trial test pick respond best needed doctors know patients common cancer men uk number people diagnosed rising 10 years probably population getting older people having psa tests 30 men advanced stage 4 prostate cancer survive cancer years diagnosis immunotherapy tremendous benefits cancer patients fantastic news prostate cancer not immune activity proportion men responding treatment says professor paul workman chief executive institute cancer research limitation immunotherapy good test pick likely respond encouraging testing dna repair mutations identify patients likely respond keen new larger trial group patients plays professor johann de bono consultant